Search

The MSK Clinical Research Roundup keeps physicians up to date on the latest and most noteworthy patient treatments, clinical trials, and translational research happening at MSK.

… Thursday, August 11, 2022 Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma (RCC)   (1) The combination of cabozantinib and nivolumab has been shown to be effective in treating clear-cell renal cell carcinoma (RCC) but has been unproven in non-clear-cell

Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms’ tumors. Their findings could help doctors identify children who are at risk for disease recurrence and precisely tailor treatment to overcome drug resistance.

… Thursday, August 8, 2019 Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms’ tumors. Their findings could help doctors identify children who are at

Meet the winners of the 2022 Robbins Family Awards for Excellence at Memorial Sloan Kettering Cancer Center.

… Wednesday, May 11, 2022 There was extra jubilation at this year’s Robbins Family Awards for Nursing Excellence , because they were held in person in the Rockefeller Research Laboratory auditorium for the first time since 2019. The May 11, 2022, event, named for longtime board member Clifton S. Robbins

Memorial Sloan Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body's inflammatory and immunological responses to them play in the development of cancer.

… Tuesday, June 1, 2010 Summary Memorial Sloan Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body’s inflammatory and immunological responses to them play in the development of cancer. Experts estimate that up to 30 percent of

Learn more about the risks and benefits of the shingles vaccine for cancer patients and their caregivers.

… Tuesday, January 13, 2026 If you have cancer, you are at high risk for shingles, a painful rash caused by the same virus as chickenpox. The shingles vaccine is safe and helps protect you. We strongly recommend the shingles vaccine for people in our care with cancer.​ Mini Kamboj, MD , MSK’s Chief Medical

Learn how a support group could help you if you’ve been diagnosed with metastatic breast cancer.

… Tuesday, October 17, 2017 Summary A support group can be beneficial for any person diagnosed with cancer but especially those with metastatic breast cancer . Social worker Roz Kleban explains why. Nothing about cancer is easy, and Roz Kleban understands that. Ms. Kleban has been a social worker in the

Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.

… Tuesday, July 19, 2016 Summary Soft tissue sarcoma describes a group of rare cancers that grow in the body’s supportive and connective tissues. MSK investigators are improving the diagnosis and treatment of sarcoma. Highlights Research into the genetic causes of sarcoma is leading to a better understanding

There has been much recent excitement about immunotherapy and the use of genetically engineered chimeric antigen receptor (CAR) T cells. Historically, CAR T cell immunotherapy has aimed to boost the immune system by giving immune cells the information they need to better recognize tumor cells as foreign and attack them. New work led by Hans-Guido Wendel, MD, of Memorial Sloan Kettering Cancer Center (MSK), and collaborator Karin Tarte of the University of Rennes, France, illustrates an untapped potential of CAR T cells to act as targeted delivery vehicles that can function as “micro-pharmacies” for precise therapeutic delivery.

… Thursday, September 29, 2016 VIDEO | 00:49 CART Cells That Function as Micro-Pharmacies Dr. Hans Guido Wendel explains the untapped potential of CAR T cells to act as targeted delivery vehicles that can function as “micro-pharmacies” for precise therapeutic delivery. Video Details There has been much

MSK worked tirelessly to provide the COVID-19 vaccine to patients and employees.

… Thursday, April 1, 2021 Giving COVID-19 vaccines to MSK patients has been an urgent mission for the hospital this year. Knowing that patients are anxious about getting protected from the virus, which is especially devastating to people with cancer, the MSK COVID-19 Vaccine Care Team and countless other

New research has found that a precancerous blood condition can linger undetected for more than 20 years.

… Monday, October 23, 2017 Summary New research has found that a precancerous blood condition can linger undetected for more than 20 years. The findings suggest that screening tests may be appropriate for some people. The medical community is always learning more about the hereditary nature of cancer.